(Q33715073)

28 July 2017

title

Open-label add-on treatment trial of minocycline in fragile X syndrome (English)

1 reference

28 July 2017

1 reference

1 reference

Carlo Paribello

1

1 reference

28 July 2017

Leeping Tao

2

1 reference

28 July 2017

Anthony Folino

3

1 reference

28 July 2017

Elizabeth Berry-Kravis

4

1 reference

28 July 2017

Michael Tranfaglia

5

1 reference

28 July 2017

Iryna M Ethell

6

1 reference

28 July 2017

Douglas W Ethell

7

1 reference

28 July 2017

publication date

11 October 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

91

1 reference

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

The mGluR theory of fragile X mental retardation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Phenotypic variation and FMRP levels in fragile X.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

The neuroanatomy and neuroendocrinology of fragile X syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

New insights into fragile X syndrome: from molecules to neurobehaviors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Risperidone in children with autism and serious behavioral problems

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Dendritic anomalies in disorders associated with mental retardation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Minocycline-induced lupus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

The fragile X syndrome: from molecular genetics to neurobiology

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Functional brain activation during arithmetic processing in females with fragile X Syndrome is related to FMR1 protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Dendritic spine structural anomalies in fragile-X mental retardation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Psychopharmacology in fragile X syndrome--present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Chronic minocycline-induced autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Minocycline as adjunctive therapy for schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-91

Epilepsy in fragile X syndrome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

FMRP expression as a potential prognostic indicator in fragile X syndrome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958860

Safety of long-term high-dose minocycline in the treatment of acne

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20937127

12 December 2020

inferred from PubMed ID database lookup

Prevalence of fragile X syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20937127

12 December 2020

inferred from PubMed ID database lookup

Benefit-risk assessment of acne therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20937127

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2377-10-91

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-10-91

release_nh5tugqe65h67jmw7f7fkmnj3y

9 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nh5tugqe65h67jmw7f7fkmnj3y

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2958860

1 reference

28 July 2017

1 reference